Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: A case for procalcitonin

Journal of Infection

Volumn 64, Issue 5, 2012, Pages 484-493

  Hoeboer, Sandra H ^a   Alberts, Erna ^a   Van den Hul, Ingrid ^a   Tacx, Annelies N ^a   Debets Ossenkopp, Yvette J ^a   Groeneveld, Johan A B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bacteraemia; Biomarker; Critically ill; Septic shock

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; LACTIC ACID; PROCALCITONIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOODSTREAM INFECTION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FEVER; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; CRITICAL ILLNESS; FEMALE; FEVER OF UNKNOWN ORIGIN; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEPSIS; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84859855481     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.01.002     Document Type: Article

References (39)

1. Fraunberger P., Wang Y., Holler E., Parhofer K.G., Nagel D., Walli A.K., et al. Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 2006, 26:10-12.
2. Laupland K.B., Shahpori R., Kirkpatrick A.W., Ross T., Gregson D.B., Stelfox H.T. Occurrence and outcome of fever in critically ill adults. Crit Care Med 2008, 36:1531-1535.
3. World Health Organization (WHO) WHO report on infectious disease: removing obstacles to healthy development 1999.
4. Clyne B., Olshaker J.S. The C-reactive protein. J Emerg Med 1999, 17:1019-1025.
5. Selberg O., Hacker H., Martin M., Klos A., Bautsch W., Köhl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein commplement 3a, and interleukin-6. Crit Care Med 2000, 28:2793-2798.
6. Linscheid P., Seboek D., Nylen E.S., Langer I., Schlatter M., Becker K.L., et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003, 144:5578-5584.
7. Gibot S., Cravoisy A., Kolopp-Sarda M.N., Béné M.C., Faure G. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 2005, 33:792-796.
8. Póvoa P., Coelho L.l., Almeida E., Fernandes A., Mealha R., Moreira P., et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005, 11:101-108.
9. Rau B.M., Kemppainen E.A., Gumbs A.A., Büchler M.W., Wegscheider K., Bassi C., et al. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis. Arch Surg 2007, 142:134-142.
10. Nakamura A., Wada H., Ikejiri M., Hatada T., Sakurai H., Matsushima Y., et al. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock 2009, 31:586-591.
11. Tschaikowsky K., Hedwig-Geissing M., Braun G.G., Radespiel-Troeger M. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care 2011, 26(26):54-64.
12. Howell M.D., Donnino M., Clardy P., Talmor D., Shaprio N.I. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med 2007, 33:1892-1899.
13. Trzeciak S., Dellinger R.P., Chansky M.E., Arnold R.C., Schorr C., Milcarek B., et al. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med 2007, 33:970-977.
14. Nichol A.D., Egi M., Pettilä V., Bellomo R., French C., Hart G., et al. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-center study. Crit Care 2010, 14:R25.
15. Simon L., Gauvin F., Amre D.K., Saint-Louis P., Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39:206-217.
16. Kofoed K., Andersen O., Kronborg G., Tvede M., Petersen J., Eugen-Olsen J., et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 2007, 11:R38.
17. Luzzani A., Polati E., Dorizzi R., Rungatscher A., Pavan R., Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003, 31:1737-1741.
18. Meisner M., Adina H., Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006, 10:R1.
19. Uzzan B., Cohen R., Nicolas P., Cucherrat M., Perret G.-Y. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34:1996-2003.
20. Tang B.M.P., Eslick G.D., Craig J.C., McLean A.S. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet 2007, 7:210-217.
21. Castelli G.P., Pognani C., Cita M., Paladini R. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 2009, 37:1845-1849.
22. Harbarth S., Holeckova K., Froidevaux C., Pitttet D., Ricou B., Grau G.E., et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164:396-402.
23. Bell K., Wattie M., Byth K., Silvestrini R., Clark P., Stachowski E., et al. Procalcitonion: a marker of bacteraemia in SIRS. Anaesth Intensive Care 2003, 31:629-636.
24. Jones A.E., Fiechtl J.F., Brown M.D., Ballew J.J., Kline J.A. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007, 50:34-41.
25. Laupland K.B., Zygun D.A., Davies D., Church D.L., Louie T.J., Doig C.J. Population-based assessment of intensive care unit-acquired bloodstream infections in adults: incidence, risk factors, and associated mortality rate. Crit Care Med 2002, 30:2462-2467.
26. Corona A., Bertolini G., Lipman J., Wilson P., Singer M. Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC). J Antimicrob Chemother 2010, 65:1276-1285.
27. Hensler T., Sauerland S., Lefering R., Nagelschmidt M., Bouillon B., Andermahr J., et al. The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock 2003, 20:420-426.
28. Clec'h C., Fosse J.-P., Karoubi P., Vincent F., Chouahi I., Hamza L., et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006, 34:102-107.
29. Charles P.E., Kus E., Aho S., Prin S., Doise J.M., Olsson N.O., et al. Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report. BMC Infect Dis 2009, 9:49.
30. Bouadma L., Luyt C.-E., Cracco C., Alvarez A., Schwebel C., Schortgen F., et al. PRORATA trial group: use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicenter randomised controlled trial. Lancet 2010, 375:463-474.
31. Heyland D.K., Johnson A.P., Reynolds S.C., Muscedere J. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit Care Med 2011, 39:1792-1799.
32. Phua J., Koay E.S.C., Lee K.H. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 2008, 29:328-333.
33. Schuetz P., Christ-Crain M., Morgenthaler N.G., Struck J., Bergmann A., Müller B. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium 2007, 14:345-351.
34. Guignant C., Voirin N., Venet F., Poitevin F., Malcus C., Bohé J., et al. Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med 2009, 35:1859-1867.
35. Jochberger S., Dorler J., Luckner G., Mayr V.D., Wenzel V., Ulmer H., et al. The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit Care Med 2009, 37:476-482.
36. Krüger S., Ewig S., Giersdorf S., Hartmann O., Suttorp N., Welte T. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia. Am J Respir Crit Care Med 2010, 182:1426-1434. the German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group.
37. Calandra T., Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005, 33:1538-1548.
38. Bundgaard H., Kjeldsen K., Suarez Krabbe K., van Hall G., Simonsen L., Qvist J., et al. Endotoxemia stimulates skeletal muscle Na+-K+-ATPase and raises blood lactate under aerobic conditions in humans. Am J Physiol Heart Circ Physiol 2003, 284:H1028-H1034.
39. De Kruif M.D., Lemaire L.C., Giebelen I.A., Struck J., Morgenthaler N.G., Papassotiriou J., et al. The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med 2008, 34:518-522.